Patents by Inventor Olivier Voinnet

Olivier Voinnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11160278
    Abstract: The use of specific active substances, alone or in combination, for controlling virus infections in plants and a method for using said specific active substances for controlling said virus infections in the field of plant protection and the protection of materials are disclosed.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: November 2, 2021
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Rachel Baltz, David Bernier, Florence Jay-Brioudes, Thomas Knobloch, Maxime Vitel, Olivier Voinnet
  • Publication number: 20190335752
    Abstract: The use of specific active substances, alone or in combination, for controlling virus infections in plants and a method for using said specific active substances for controlling said virus infections in the field of plant protection and the protection of materials are disclosed.
    Type: Application
    Filed: January 12, 2017
    Publication date: November 7, 2019
    Inventors: Rachel BALTZ, David BERNIER, Florence JAY-BRIOUDES, Thomas KNOBLOCH, Maxime VITEL, Olivier VOINNET
  • Patent number: 10440952
    Abstract: The present invention relates to the use of specific active substances, alone or in combination, for controlling virus infections in plants and to a method for using said specific active substances for controlling said virus infections in the field of plant protection and the protection of materials.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: October 15, 2019
    Assignee: Bayer Corp Science Aktiengesellschaft
    Inventors: Rachel Baltz, David Bernier, Florence Jay-Brioudes, Thomas Knobloch, Maxime Vitel, Olivier Voinnet
  • Publication number: 20190053490
    Abstract: The use of specific active substances, alone or in combination, for controlling virus infections in plants and a method for using said specific active substances for controlling said virus infections in the field of plant protection and the protection of materials are disclosed.
    Type: Application
    Filed: January 12, 2017
    Publication date: February 21, 2019
    Inventors: Rachel BALTZ, David BERNIER, Florence JAY-BRIOUDES, Thomas KNOBLOCH, Maxime VITEL, Olivier VOINNET
  • Publication number: 20190021327
    Abstract: The present invention relates to the use of specific active substances, alone or in combination, for controlling virus infections in plants and to a method for using said specific active substances for controlling said virus infections in the field of plant protection and the protection of materials.
    Type: Application
    Filed: January 12, 2017
    Publication date: January 24, 2019
    Applicant: Bayer Corp Science Aktiengesellschaft
    Inventors: Rachel BALTZ, David BERNIER, Florence JAY-BRIOUDES, Thomas KNOBLOCH, Maxime VITEL, Olivier VOINNET
  • Patent number: 8871997
    Abstract: Disclosed are a variety of methods for achieving enhanced expression from a target nucleotide sequence in a plant e.g. comprising the step of transiently introducing into a tissue of a plant (e.g. a leaf) a first nucleic acid comprising the target nucleotide sequence and a second nucleic acid encoding a Post Transcriptional Gene Silencing (PTGS) suppressor protein (preferably of viral or plant origin), wherein the first and second nucleic acids are comprised within a single binary vector, construct, or the first and second nucleic acid sequences are comprised within a first binary vector and a second binary vector construct respectively. The plant tissue may then be harvested for the protein. Such methods can give much higher levels of gene expression than are obtainable using stable transgenes, or certain replicating vectors.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: October 28, 2014
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Olivier Voinnet, Andrew John Hamilton
  • Publication number: 20110177054
    Abstract: The present invention relates to a method for determining the delivery rates and/or efficiency of a siRNA, miRNA or related molecule to target organs or cells, a kit and the use of proteins or lipids involved in the formation of the endolysosomal system for modulating the activity and/or the cell-to-cell transfer of RNA, small RNA, for example miRNA, siRNA and piRNA, mRNA or non-coding RNA. It finds many applications in particular in methods for identifying the target(s) of miRNA or siRNA therapeutics, in methods for determining the efficiency of a treatment with siRNA and/or miRNA therapeutics, in methods for determining the efficiency of a treatment with siRNA and/or miRNA therapeutics, and in methods for genotyping and/or characterizing the condition of a person, a tumor or a fetus.
    Type: Application
    Filed: June 5, 2009
    Publication date: July 21, 2011
    Inventors: Derrick Gibbings, Olivier Voinnet
  • Publication number: 20090029932
    Abstract: The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukemia and to a method for identifying therapeutic agents or the efficient combination thereof for inducing the differentiation of myelogenous leukemia cells.
    Type: Application
    Filed: May 3, 2007
    Publication date: January 29, 2009
    Applicant: Centre National De La Recherche Scientifique (CNRS)
    Inventors: Olivier Voinnet, Charles-Henri Lecellier, Anne Saumet, Michel Lanotte
  • Publication number: 20070292862
    Abstract: Disclosed are a variety of methods for achieving enhanced expression from a target nucleotide sequence in a plant e.g. comprising the step of transiently introducing into a tissue of a plant (e.g. a leaf) a first nucleic acid comprising the target nucleotide sequence and a second nucleic acid encoding a Post Transcriptional Gene Silencing (PTGS) suppressor protein (preferably of viral or plant origin), wherein the first and second nucleic acids are comprised within a single binary vector, construct, or the first and second nucleic acid sequences are comprised within a first binary vector and a second binary vector construct respectively. The plant tissue may then be harvested for the protein. Such methods can give much higher levels of gene expression than are obtainable using stable transgenes, or certain replicating vectors.
    Type: Application
    Filed: November 20, 2006
    Publication date: December 20, 2007
    Inventors: David Baulcombe, Olivier Voinnet, Andrew Hamilton
  • Patent number: 7217854
    Abstract: Disclosed are a variety of methods for achieving enhanced expression from a target nucleotide sequence in a plant e.g. comprising the step of transiently introducing into a tissue of a plant (e.g. a leaf) a first nucleic acid comprising the target nucleotide sequence and a second nucleic acid encoding a Post Transcriptional Gene Silencing (PTGS) suppressor protein (preferably of viral or plant origin), wherein the first and second nucleic acids are comprised within a single binary vector construct, or the first and second nucleic acid sequences are comprised within a first binary vector and a second binary vector construct respectively. The plant tissue may then be harvested for the protein. Such methods can give much higher levels of gene expression than are obtainable using stable transgenes, or certain replicating vectors.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: May 15, 2007
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Olivier Voinnet, Andrew John Hamilton
  • Publication number: 20050214263
    Abstract: Provided are methods of silencing a target gene in an organism, which methods comprises the steps of: (a) providing a recombinant DNA construct including an expression cassette comprising: (i) a promoter, operably linked to, (ii) a chimeric nucleotide sequence encoding all or part of the target gene and a transgene, (b) transforming the organism with said DNA construct such that the expression cassette is inserted into the genome, and (c) initiating post transcriptional gene silencing (PTGS) of said transgene in said organism, whereby initiation of PTGS of the transgene causes silencing of the target gene in the organism. The methods are based on a phenomenon termed “spreading” whereby PTGS of the transgene can be used to spread in trans to silence, for example, endogenous target genes in the same genetic background as the chimeric gene to give consistent, maintained, silencing thereof. Also provided are related materials (e.g. recombinant constructs) and uses and methods based on these.
    Type: Application
    Filed: December 5, 2002
    Publication date: September 29, 2005
    Inventors: Fabian Vaistij, Olivier Voinnet, David Baulcombe
  • Publication number: 20030229920
    Abstract: Disclosed are methods for silencing a target nucleotide sequence (preferably representing one or more endogenous genes, preferably in a systemic fashion) which is present in a first part of the plant, which method comprises transiently introducing into the cytoplasm of a cell in a second part of the plant, which cell comprises a nucleic acid encoding the target sequence and which is remote from said first part of the plant, a nucleic acid construct.
    Type: Application
    Filed: March 5, 2003
    Publication date: December 11, 2003
    Inventors: David Charles Baulcombe, Olivier Voinnet, Carsten Werner Lederer
  • Patent number: 6531647
    Abstract: Disclosed are methods for silencing a target nucleotide sequence (preferably representing one or more endogenous genes, preferably in a systemic fashion) which is present in a first part of the plant, which method comprises transiently introducing into the cytoplasm of a cell in a second part of the plant, which cell comprises a nucleic acid encoding the target sequence and which is remote from said first part of the plant, a nucleic acid construct.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: March 11, 2003
    Assignee: Plant Bioscience Limited
    Inventors: David Charles Baulcombe, Olivier Voinnet, Carsten Werner Lederer